Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Scholar Rock Holding Corp SRRK

Healthcare Biotechnology
Scholar Rock Holding Corporation is a biopharmaceutical company. The Company is focused on the discovery, development and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFb) superfamily biology, its novel molecular mechanisms of growth factor activation enabled the Company... see more

Recent & Breaking News (NDAQ:SRRK)

Scholar Rock Appoints Tony Kingsley to Its Board of Directors

Business Wire May 21, 2020

Scholar Rock Presents Baseline Demographics Data from the SRK-015 TOPAZ Trial at the American Academy of Neurology Conference

Business Wire May 18, 2020

Scholar Rock Reports First Quarter 2020 Financial Results and Highlights Business Progress

Business Wire May 7, 2020

Scholar Rock Announces Initiation of Patient Dosing in Phase 1 Proof-of-Concept Immuno-Oncology Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 Therapy

Business Wire May 5, 2020

Scholar Rock Announces Issuance of U.S. Patent Broadly Relevant to Antibodies that Modulate TGF? Activation

Business Wire April 9, 2020

Scholar Rock Announces Publication in Science Translational Medicine of Preclinical Data Detailing a Potent and Selective Inhibitor of TGF?1 Overcoming Primary Resistance to Checkpoint Inhibition

Business Wire March 26, 2020

Scholar Rock Presents Data for SRK-015 at the Muscular Dystrophy Association Clinical and Scientific Conference

Business Wire March 24, 2020

Scholar Rock Reports Full Year 2019 Financial Results and Highlights Business Progress

Business Wire March 12, 2020

Scholar Rock to Present at the Cowen 40th Annual Healthcare Conference

Business Wire February 26, 2020

Scholar Rock Presents Data for SRK-015 at the SMA Europe 2nd International Scientific Congress

GlobeNewswire February 6, 2020

Scholar Rock Provides Corporate Update and Outlines Key R&D Priorities for 2020

GlobeNewswire January 10, 2020

Scholar Rock Achieves First Milestone in Strategic Fibrosis Collaboration with Gilead Sciences

GlobeNewswire January 9, 2020

Scholar Rock Added to NASDAQ Biotechnology Index

GlobeNewswire December 19, 2019

Scholar Rock Reports Preliminary Pharmacokinetic and Pharmacodynamic Data from TOPAZ Phase 2 Trial of SRK-015 for the Treatment of Patients with Spinal Muscular Atrophy

GlobeNewswire November 19, 2019

Scholar Rock Reports Third Quarter 2019 Financial Results and Highlights Business Progress

GlobeNewswire November 12, 2019

Scholar Rock to Present at the 2019 Jefferies London Healthcare Conference

GlobeNewswire November 8, 2019

Scholar Rock to Present Preclinical and Phase 1 Clinical Data on SRK-015 at the World Muscle Society Congress

GlobeNewswire October 2, 2019

Scholar Rock Announces Appointment of George Nomikos, M.D., Ph.D., as Vice President, Head of Medical Research, Muscle Franchise

GlobeNewswire September 5, 2019

Scholar Rock to Present at Upcoming Healthcare Conferences

GlobeNewswire September 4, 2019

Scholar Rock Announces Upcoming Departure of Chief Financial Officer

GlobeNewswire August 27, 2019